Looking back at the business segment growth in 2010-2015, all segments’ sales grew and generated operating income. In particular, the Semiconductor Instruments & Systems and Automotive Test Systems segments grew significantly but sales and operating income of the Medical-Diagnostic Instruments & Systems segment fell short of expectations.
The business portfolio target for 2020, under the MLMAP 2020 which began in 2016, envisions well-balanced growth and profitability in all business segments. In addition to seeking business growth of each segment, we will promote mutual use of technology and sales network of each business segment, which also means challenging new businesses and new applications. The operating income ratio of 10% or more in all business segments is also a part of the new plan’s targets.